New shot aims to keep liver cancer away after treatment
Disease control
Recruiting now
This study tests a single injection of IP-001 given right after surgery or ablation for liver cancer (hepatocellular carcinoma). The goal is to see if it can safely delay or prevent the cancer from returning. About 126 adults with high-risk liver cancer will take part and be foll…
Phase: PHASE2 • Sponsor: Robert C. Martin • Aim: Disease control
Last updated May 17, 2026 04:32 UTC